Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Allarity Therapeutics Europe ApS
APS
Active
CVR 34623562
Venlighedsvej 1, 2970
Hørsholm
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2012
4 employees
Watchlist
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Allarity Therapeutics Europe ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
-4M
-7M
-11M
-15M
-13M
2020
-80M
2021
-43M
2022
-49M
2023
-45M
2024
EBITDA
DKK millions
0M
-5M
-9M
-14M
-18M
-16M
2020
-80M
2021
-52M
2022
-56M
2023
-48M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-13.158
-79.617
-42.967
-49.354
-44.548
Staff expenses
-2.929
-24
-8.775
-6.261
-3.530
EBITDA
-16.087
-79.641
-51.742
-55.615
-48.078
Depreciation & amort.
-823
-333
-118.683
-196
-348.712
EBIT
-16.910
-79.974
-170.425
-55.811
-396.790
Net financials
-3.997
36.320
-4.026
1.533
-14.900
Profit before tax
-20.907
-43.654
-173.647
-54.278
-411.690
Tax
-2.350
32.625
-31.209
-5.543
-17.872
Net profit
-18.557
-76.279
-142.438
-48.735
-393.818
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
38.170
498.792
365.943
362.236
11.249
Equity
-147.061
386.284
243.758
195.023
-198.795
Long-term debt
171.049
6.423
0
0
0
Short-term debt
14.182
67.563
109.770
154.841
210.044
Total debt
185.231
73.986
109.770
154.841
210.044
Financial ratios
5-year trend
EBITDA margin
-4807800000.0%
This company
15.8%
Market median
-30429114024% vs market
2020
2024
Equity ratio
-1767.2%
This company
38.2%
Market median
-4726% vs market
2020
2024
Return on equity
-39381800000.0%
This company
18.4%
Market median
-214031521839% vs market
2020
2024
Net profit margin
-39381800000.0%
This company
8.1%
Market median
-486195061828% vs market
2020
2024
Asset turnover
-3.96×
This company
1.12×
Market median
-454% vs market
2020
2024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Allarity Therapeutics Europe ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
